Figures & data
Figure 1. Rho-kinase inhibitors in clinical use, ripasudil and netarsudil.
Foreword
The management of glaucoma and macular degeneration
Claudiu T SupuranNEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Firenze, ItalyCorrespondence[email protected]
https://orcid.org/0000-0003-4262-0323View further author information
https://orcid.org/0000-0003-4262-0323View further author informationReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.